News | ASTRO | December 20, 2022

ASTRO's statement stresses that it is deeply disappointed in radiation oncology cuts and fears for stability of community-based cancer clinics

ASTRO's statement stresses that it is deeply disappointed in radiation oncology cuts and fears for stability of community-based cancer clinics

Getty Images


December 20, 2022 — The American Society for Radiation Oncology (ASTRO) issued the following statement from ASTRO Board of Directors Chair Geraldine Jacobson, MD, MBA, MPH, FASTRO, in response to today’s release of the Fiscal Year 2023 Omnibus Appropriations bill.
"On behalf of ASTRO’s 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other healthcare professionals who specialize in treating cancer patients with radiation therapy, ASTRO is disappointed that Congress failed to stop the full Medicare physician payment cuts for 2023, demonstrating that the Medicare physician payment system is broken. Radiation oncology has faced among the most significant cuts of any medical specialty, leaving community-based clinics at the breaking point. We urge the new Congress to immediately begin payment reform discussions, including working with ASTRO and the radiation oncology community to create a new, sustainable payment approach for radiation therapy services.

The omnibus package leaves all physicians with a 2% reduction in the Medicare physician payment conversion factor for 2023, and radiation oncology with an additional 1% decrease due to clinical labor price changes, at a time when patients are returning to clinics and facing more complex cancer care due to delays caused by the pandemic. Cancer clinics must also contend with a wide range of increasing overhead and staffing costs when determining their ability to provide care to Medicare beneficiaries. Payment relief in the omnibus bill is insufficient and could endanger some clinics’ ability to stay open and provide needed care to people with cancer.”

For more information: www.astro.org


Related Content

Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
News | Stereotactic Body Radiation Therapy (SBRT) | American Society for Radiation Oncology

Sept. 29, 2025 — A new clinical trial report finds that stereotactic radiation therapy offers long-term survival ...

Time October 15, 2025
arrow
News | Proton Therapy

Sept. 28, 2025 — Leo Cancer Care has launched Grace, the company's upright photon therapy system. Grace is named after ...

Time October 03, 2025
arrow
News | Prostate Cancer

Sept. 30, 2025 – EDAP TMS's non-invasive, nonsurgical treatment option, Focal One Robotic HIFU, was featured on national ...

Time September 30, 2025
arrow
News | Radiation Therapy | American Society for Radiation Oncology (ASTRO)

Sept. 29, 2025 — Radiation therapy may offer a comparable and potentially safer alternative to repeat catheter ablation ...

Time September 30, 2025
arrow
News | Radiation Therapy

Sept. 26, 2025 – Accuray Inc. has introduced the Accuray Stellar* solution. Initially for the U.S. market, the new ...

Time September 29, 2025
arrow
News | Computed Tomography (CT)

Sept. 26, 2025 — At the American Society for Radiation Oncology (ASTRO) 2025 annual meeting in San Francisco, Calif ...

Time September 29, 2025
arrow
News | Lung Imaging

Sept. 26, 2025 ― Researchers from the University of Texas MD Anderson Cancer Center will present new data at the ...

Time September 29, 2025
arrow
News | ASTRO

Sept. 26, 2025 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive ...

Time September 29, 2025
arrow
News | Radiation Therapy

Sept. 25, 2025 — GE HealthCare has announced updates to Intelligent Radiation Therapy (iRT), a new version of the ...

Time September 25, 2025
arrow
Subscribe Now